CJC 1295(without DAC)

Overview: What is CJC 1295 (without DAC)?

CJC 1295 (without DAC) is a research peptide commonly studied for its role as a growth hormone-releasing hormone (GHRH) analog. By stimulating growth hormone secretion, research indicates its potential usefulness in investigating cellular repair, protein synthesis, and metabolic regulation.

Key Research Benefits

Studies suggest that CJC 1295 (without DAC) may support multiple areas of scientific exploration, including:

• Promotion of protein synthesis and cellular repair pathways.
• Investigation of age-related hormonal modulation effects.
• Potential support for energy metabolism-related studies.
• Exploration of tissue regeneration mechanisms.

Mechanism of Action

Research on CJC 1295 (without DAC) demonstrates that it acts by mimicking endogenous GHRH, binding to specific receptors in the pituitary gland. This interaction stimulates growth hormone release in a pulsatile manner, distinguishing it from its DAC-containing counterpart. Importantly, CJC 1295 (without DAC) has a shorter half-life, making it a unique tool for timing-specific research.

Technical & Storage Specifications

Below are the standard technical parameters for CJC 1295 (without DAC):

FAQs

1. What is the difference between CJC 1295 with and without DAC?
CJC 1295 with DAC includes a drug affinity complex (DAC) that extends its half-life and increases the duration of growth hormone release, while the version without DAC induces a shorter-term pulse but allows for focused application in research.

2. How should it be stored after reconstitution?
After reconstitution, CJC 1295 (without DAC) should be stored at 2-8°C, away from direct light, to preserve stability and potency.

3. Is third-party testing (CoA) available?
Yes, Certificates of Analysis (CoA) from accredited third-party laboratories are available upon request to ensure quality and purity of the peptide.